Market Exclusive

Eli Lilly and Company (NYSE:LLY) reported earnings of $1.05 per share beating Walls Streets expectations.

Eli Lilly and Company (NYSE:LLY) reported Q3 2017 earnings this Morning, coming in at $1.05 per share, beating Wall Street’s estimates of $1.03 per Share. Revenue for the quarter came in at $5.66 billion beating analyst estimates of $5.52 billion

Analyst Coverage For Eli Lilly and Company (NYSE:LLY)
These are 1 Sell Rating, 7 Hold Ratings, 10 Buy Ratings .
The current consensus rating for Eli Lilly and Company (NYSE:LLY) is Buy (Score: 2.50) with a consensus target price of $90.18 , a potential (3.44% upside)Recent Insider Trading for Eli Lilly and Company (NYSE:LLY)

Dividend History for Eli Lilly and Company (NYSE:LLY)

Recent Trading for Eli Lilly and Company (NYSE:LLY) Shares of Eli Lilly and Company closed the previous trading session at with shares trading hands.

Exit mobile version